drugset / Trial / NCT02237547
Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
NaSingle-groupOpen-labelTreatment
Summary
Human Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSC) and Bone Marrow Mononuclear Cells (BMMC) from the patient injected into the spinal fluid intrathecally and injected intravenously (IV) is a safe and therapeutic procedure for spinal cord injury (SCI) patients.
Timeline
- Start
- 2014-09
- Primary completion
- 2019-01
- Completion
- 2019-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human umbilical cord tissue-derived mesenchymal stem cells | Cell therapy | — | Intrathecal |
| Subject | bone marrow mononuclear cells | Cell therapy | — | Intrathecal |